Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
AI-native platform digitizing pharma manufacturing shop-floor execution, batch records, and quality workflows.
Leucine, founded in 2019 with engineering headquarters in Bengaluru, India, and a U.S. commercial office, provides an AI-based platform that digitizes batch records, shop-floor execution, and quality workflows for pharmaceutical manufacturers. The company raised $7 million in funding led by Ecolab. It publishes extensive content on GMP compliance, but no vendor-held security certifications were found on its site — certification status should be confirmed directly during evaluation.
57% — Partial coverage. Coverage score — how completely Atlas documents Leucine across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Biotech Startup, Mid-Size Biotech, Large Pharma, IT / Digital, Data Management
Manufacturing Process Optimization, Manufacturing Quality Control
Private, $7.0M raised, Founded 2019
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?